Ventures III General Partner Ltd Phase4 serves as Executive at ALBIREO PHARMA, INC., where they oversee executive responsibilities. Since joining the company, Ventures III General Partner Ltd Phase4 has executed 2 insider transactions totaling $3.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 30, 2018 involved selling 1,500 shares valued at $55.6K.
Ventures III General Partner Ltd Phase4 currently holds 1,065,447 shares of ALBIREO PHARMA, INC. (ALBO), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Ventures III General Partner Ltd Phase4 has been a net seller of ALBO stock. They have purchased $0 and sold $3.4M worth of shares.
Ventures III General Partner Ltd Phase4's most recent insider trade was on Jan 30, 2018, when they sold 1,500 shares at $37.06 per share.
Get notified when new Form 4 filings are submitted
| $34.40 |
| Discretionary |